Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Thomson

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Molecular Cell|June 15, 2010
Monoubiquitination of RPN10 regulates substrate recruitment to the proteasomeMarta Isasa, Elijah J Katz, Woong Kim, et al.
Cancer Research|December 18, 2004
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinomaJesús Planagumà, María Díaz-Fuertes, Antonio Gil-Moreno, et al.
International Journal of Cancer|June 17, 2009
HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cellsMarta Soler, Francesca Mancini, Oscar Meca-Cortés, et al.
Science (New York, N.Y.)|November 17, 2007
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligaseNadine K Kolas, J Ross Chapman, Shinichiro Nakada, et al.
Oncotarget|July 9, 2016
A key role for transketolase-like 1 in tumor metabolic reprogrammingSantiago Diaz-Moralli, Esther Aguilar, Silvia Marin, et al.
BMC Cancer|November 1, 2008
Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancerRaquel Bermudo, David Abia, Berta Ferrer, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease InhibitorsMaria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, et al.
Frontiers in Immunology|September 19, 2022
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomesLeire Pedrosa, Carles Foguet, Helena Oliveres, et al.
Oncogene|July 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cellsMíriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada, et al.
Journal of Lipid Research|February 21, 2013
Acid ceramidase as a therapeutic target in metastatic prostate cancerLuz Camacho, Oscar Meca-Cortés, José Luis Abad, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Molecular Cell|June 15, 2010
Monoubiquitination of RPN10 regulates substrate recruitment to the proteasomeMarta Isasa, Elijah J Katz, Woong Kim, et al.
Cancer Research|December 18, 2004
A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinomaJesús Planagumà, María Díaz-Fuertes, Antonio Gil-Moreno, et al.
International Journal of Cancer|June 17, 2009
HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cellsMarta Soler, Francesca Mancini, Oscar Meca-Cortés, et al.
Science (New York, N.Y.)|November 17, 2007
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligaseNadine K Kolas, J Ross Chapman, Shinichiro Nakada, et al.
Oncotarget|July 9, 2016
A key role for transketolase-like 1 in tumor metabolic reprogrammingSantiago Diaz-Moralli, Esther Aguilar, Silvia Marin, et al.
BMC Cancer|November 1, 2008
Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancerRaquel Bermudo, David Abia, Berta Ferrer, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease InhibitorsMaria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, et al.
Frontiers in Immunology|September 19, 2022
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomesLeire Pedrosa, Carles Foguet, Helena Oliveres, et al.
Oncogene|July 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cellsMíriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada, et al.
Journal of Lipid Research|February 21, 2013
Acid ceramidase as a therapeutic target in metastatic prostate cancerLuz Camacho, Oscar Meca-Cortés, José Luis Abad, et al.
Pageof 6